Latest Personalized medicine Stories
BILLERICA, Mass., Oct.
The market is mainly driven by the increasing research funding for metabolomics from governments and private investors, growing demand for personalized medicine in the U.S.
Fast-rising Asia-Pacific emerges as latest hotspot for IVD manufacturers MOUNTAIN VIEW, Calif., Oct.
LEWISVILLE, Texas and CLEVELAND, Oct.
The transcriptomics market has witnessed significant growth in the past few years mainly due to the increasing technological advancements in the field of ‘omics’ research and application of
Canada Cancer and Aging Research Laboratory (CCARL) launched in Lethbridge to provide personalized diagnostic and medical solutions for cancer treatment and to develop diagnostic criteria and
GHENT, Belgium and MADRID, October 7, 2014 /PRNewswire/ -- MyCartis today announced the launch of Evalution(TM), a multiplex biomarker analysis platform for the life sciences
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.